Last week, Abhijit Banerjee, Esther Duflo and Michael Kremer accepted the 2019 Nobel Memorial Prize in Economic Sciences. They were recognized for their use of randomized controlled trials, also known ...

The U.S. health care system is often inefficient, ineffective, and inequitable. Compared to other high-income countries, the U.S. pays more for health care and has worse outcomes. One potentially ...

Section 1115 waivers in the Medicaid program are meant to be experiments for states to test coverage approaches that don't meet federal requirements. However, most of those evaluations fall far short, ...

At Innovations for Poverty Action, we disagree with Lisbeth B. Schorr’s assessment that rigorous evaluation methods will inhibit innovation in social policy. In fact, randomized trials offer the best ...

This paper uses a public economics framework to review evidence from randomized trials on domestic water access and quality in developing countries and to assess the case for subsidies. Water ...

Editor’s note: This story was first published on Econofact. The Nobel Memorial prize in Economic Sciences awarded this year to Abhijit Banerjee, Esther Duflo, and Michael Kremer has focused attention ...

A 12-month pilot study of Pacira BioScience’s iovera for chronic lower back pain showed it was favorable compared to compared to radiofrequency ablation, according to a Dec. 2 news release.

Note: This is a guest post by Jon Baron, President of the Coalition for Evidence-Based Policy, and Chairman of the National Board for Education Sciences In today’s tough economic climate, quality ...

Randomized, evidence-based trials, long required for new drugs, are now underway for government policy initiatives. By Amy Finkelstein Facing an urgent need to determine whether new coronavirus ...